業績 | 東北大学大学院医学系研究科・加藤研究室

原著論文（ブログ/X/YouTube)

2026

441. Hitomi N, Hoshi S, Kaneko MK, Kato R, Iwasaki K, Takagi J, Kato Y, Harada-Hikita A, Arimori T.
Functional and structural characterisation of a novel anti-His-tag antibody, HisMab-1
J Mol Biol, 438(2), 169574, doi: 10.1016/j.jmb.2025.169574, 2026 (PDF)
440. Ubukata R, Suzuki H, Kaneko MK, Kato Y.
Development of novel anti-CDH1/E-cadherin monoclonal antibodies for flow cytometry, western blotting, and immunohistochemistry
BBREP, 45, 102401, https://www.sciencedirect.com/science/article/pii/S2405580825004881, 2026 (PDF; preprint)

online

Li G, Tanaka T, Kaneko MK, Suzuki H, Kato Y.
Ea5Mab-7, a novel anti-EphA5 monoclonal antibody for flow cytometry and immunohistochemistry.
Microbes & Immunity, 025300066, https://doi.org/10.36922/MI025300066, 2025 (PDF; preprint)
Fujisawa S, Ubukata R, Suzuki H, Tanaka T, Nomura A, Shinoda K, Nakamura T, Satofuka H, Li G, Kaneko MK, Kato Y.
Development of novel anti-rhinoceros podoplanin monoclonal antibodies for flow cytometry, western blot, and immunohistochemistry
Microbes & Immunity, 2025 (PDF; preprint)
Tanaka T, Sakata T, Fujisawa S, Yamamoto H, Kaneko Y, Kaneko MK, Suzuki H, Kato Y.
Establishment of a novel anti-mouse CD73 monoclonal antibody C73Mab-9 by CBIS method
Microbes & Immunity, 025220048, https://doi.org/10.36922/MI025220048, 2025 (PDF; preprint)
Fujisawa S, Yamamoto H, Tanaka T, Kaneko MK, Suzuki H, Kato Y.
Development and characterization of Ea7Mab-10: a novel monoclonal antibody targeting EphA7
Microbes & Immunity, 025220049, https://doi.org/10.36922/MI0252200492025, 2025 (PDF; preprint)
Yamamoto H, Suzuki H, Tanaka T, Satofuka H, Kaneko MK, Kato Y.
Development of a novel anti-mouse CCR7 monoclonal antibody C7Mab-2 by immunization of the extracellular loop domain
Microbes & Immunity, 025130028, https://doi.org/10.36922/MI025130028, 2025 (PDF; preprint)

proof

Li G, Suzuki H, Kaneko MK, Kato Y.
Establishment of novel anti-EphB3 monoclonal antibodies for multiple applications
MAB-2025-0014, 2025 (PDF; preprint)

Yamamoto H, Suzuki H, Tanaka T, Kaneko MK, Kato Y.
Development of an anti-Glypican-1 monoclonal antibody G1Mab-28 for flow cytometry, western blotting, and immunohistochemistry
Microbes & Immunity, 2025 (PDF; preprint)
Takuya Mizuno, Kei Harada, Masanao Ichimata, Ryuzo Katayama, Yukinari Kato, Toshinori Shiga, Toshihiro Tsukui, Hiroto Toyoda, Eri Fukazawa, Fukiko Matsuyama, Masaya Igase, Tetsuya Kobayashi.
Afucosylated anti-canine CD20 antibody combined with CHOP therapy in canine B-cell lymphoma
Journal of Veterinary Internal Medicine, 2025

revision

Taruta H, Tanaka T, Kaneko MK, Suzuki H, Kato Y.
Cx2Mab-5: a Novel anti-mouse CXCR2 monoclonal antibody developed by N-terminus peptide Immunization for multiple applications
MAB-2025-0017, 2025 (PDF; preprint)
Saga A, Li G, Tanaka T, Kaneko MK, Suzuki H, Kato Y.
Establishment of a novel anti-EphA4 monoclonal antibody, Ea4Mab-3, for versatile applications
Microbes & Immunity, 2025 (PDF; preprint)
Satofuka H, Suzuki H, Kaneko MK, Kato Y.
Development of anti-human cadherin-26 monoclonal antibody, Ca26Mab-6, for flow cytometry
Microbes & Immunity, 2025 (PDF; preprint)
Yoshida A, Abe S, Izumi T, Itakura S, Yamada K, Wada T, Yamamoto T, Sato C, Mitsuhashi A, Ogino H, Sato S, Shinohara T, Hanibuchi M, Kaneko MK, Kato Y, Nishioka Y.
Cancer-specific anti-human podoplanin antibody chLpMab-2f exerts antitumor effects against pleural mesothelioma
CAS, 2025
Ishii Y et al.,
MAT2A and S-adenosylmethionine are required for B cell activation through histone methylation
EMBO Molecular Medicine, 2025

submit

Li G, Suzuki H, Ohishi T, Satofuka H, Ishikawa K, Shimizu K, Nomura A, Araki H, Kojo N, Suzuki K, Handa S, Nakamura T, Yanaka M, Tanaka T, Kaneko MK, Kato Y.
Antitumor activities of chimeric anti-EphA2 antibodies in xenograft models of breast, pancreatic, and colorectal cancers
CAS, 2025 (PDF; preprint)
Okuno S, Suzuki H, Kaneko MK, Kato Y.
A Novel Anti-Glypican-3 Monoclonal Antibody G3Mab-25 for Flow Cytometry, Western Blotting, and Immunohistochemistry
Microbes & Immunity, DOI:10.20944/preprints202510.2209.v1, 2025 (PDF; preprint)
Sudo H, Tsuji A, Sugyo A, Kaneko MK, Kato Y, Higashi T.
Intrathoracic 90Y-NZ-16 therapy improves efficacy and reduces toxicity in pleural mesothelioma mice
Nuclear Medicine Communications, 2025
Izumi K, Furukawa E, Ishii T, Ishikawa A, Sumide K, Kaneko MK, Kato Y, Kaneko S.
Development of a Standalone Anti-PDPN CasMab CAR-T Cell Product with Tumor Specificity and Robust Antitumor Activity
Genes and Cells, 2025